|
๐
|
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries
43 auth.
A. Cortellini,
G. Dettorre,
U. Dafni,
J. Aguilar-Company,
L. Castelo-Branco,
M. Lambertini,
S. Gennatas,
Vasileios Angelis,
A. Sita-Lumsden,
J. Rogado,
P. Pedrazzoli,
D. Viรฑal,
Aleix Prat,
M. Rossi,
R. Berardi,
...
T. Alonso-Gordoa,
Salvatore Grisanti,
G. Dimopoulou,
Paola Queirolo,
S. Pradervand,
A. Bertuzzi,
M. Bower,
D. Arnold,
R. Salazar,
M. Tucci,
Kevin J Harrington,
F. Mazzoni,
U. Mukherjee,
Z. Tsourti,
O. Michielin,
F. Pommeret,
J. Brunet,
B. Vincenzi,
G. Tonini,
A. Patriarca,
F. Biello,
M. Krengli,
J. Tabernero,
G. Pentheroudakis,
A. Gennari,
S. Peters,
E. Romano,
D. Pinato
|
8 |
2022 |
8
๐
|
|
๐
|
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
39 auth.
F. Herrera,
C. Ronet,
M. Ochoa de Olza,
D. Barras,
I. Crespo,
M. Andreatta,
J. Corria-Osorio,
A. Spill,
F. Benedetti,
R. Genolet,
A. Orcurto,
M. Imbimbo,
Eleonora Ghisoni,
B. Navarro Rodrigo,
D. Berthold,
...
A. Sarivalasis,
K. Zaman,
R. Duran,
C. Dromain,
John O. Prior,
N. Schaefer,
J. Bourhis,
G. Dimopoulou,
Z. Tsourti,
Marius Messemaker,
Thomas H Smith,
S. Warren,
P. Foukas,
S. Rusakiewicz,
M. Pittet,
S. Zimmermann,
C. Sempoux,
U. Dafni,
A. Harari,
L. Kandalaft,
Santiago J. Carmona,
Denarda Dangaj Laniti,
M. Irving,
G. Coukos
|
7 |
2021 |
7
๐
|
|
๐
|
Efficacy of Adoptive Therapy with Tumor-infiltrating Lymphocytes and Recombinant Interleukin-2 in Advanced Cutaneous Melanoma: A Systematic Review and Meta-analysis.
24 auth.
U. Dafni,
U. Dafni,
O. Michielin,
S. M. Lluesma,
S. M. Lluesma,
Z. Tsourti,
V. Polydoropoulou,
D. Karlis,
M. Besser,
M. Besser,
...
J. Haanen,
I. Svane,
Pamela S. Ohashi,
U. Kammula,
A. Orcurto,
Stefan Zimmermann,
Lionel Trueb,
C. A. Klebanoff,
C. A. Klebanoff,
M. T. Lotze,
L. Kandalaft,
L. Kandalaft,
G. Coukos,
G. Coukos
|
7 |
2019 |
7
๐
|
|
๐ฌ
|
Breast Cancer Statistics in the European Union: Incidence and Survival across European Countries
U. Dafni,
Z. Tsourti,
Ioannis Alatsathianos
|
7 |
2019 |
7
๐ฌ
|
|
๐ฌ
|
Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis.
U. Dafni,
Z. Tsourti,
K. Vervita,
S. Peters
|
7 |
2019 |
7
๐ฌ
|
|
๐
|
Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP).
15 auth.
R. Dziadziuszko,
E. Smit,
U. Dafni,
J. Wolf,
B. Wasฤ
g,
W. Biernat,
S. Finn,
R. Kammler,
Z. Tsourti,
M. Rabaglio,
...
B. Ruepp,
H. Roschitzki-Voser,
R. Stahel,
E. Felip,
S. Peters
|
6 |
2019 |
6
๐
|
|
๐
|
Progression-free and overall survival for concurrent nivolumab with standard concurrent chemo-radiotherapy in locally advanced stage IIIA/B NSCLC: Results from the European Thoracic Oncology Platform NICOLAS phase II trial (ETOP 6-14).
20 auth.
S. Peters,
E. Felip,
U. Dafni,
A. Tufman,
M. Guckenberger,
R. รlvarez,
E. Nadal,
A. Becker,
H. Vees,
M. Pless,
...
A. Martรญnez-Martรญ,
M. Lambrecht,
N. Andratschke,
Z. Tsourti,
A. Piguet,
H. Roschitzki-Voser,
A. Gasca-Ruchti,
J. Vansteenkiste,
R. Stahel,
D. de Ruysscher
|
6 |
2020 |
6
๐
|
|
๐
|
Evaluation of NGS and RTโPCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project
82 auth.
I. Letovanec,
S. Finn,
P. Zygoura,
P. Smyth,
A. Soltermann,
L. Bubendorf,
E. Speel,
A. Marchetti,
D. Nonaka,
K. Monkhorst,
H. Hager,
M. Martorell,
A. Sejda,
R. Cheney,
J. Hernรกndez-Losa,
...
E. Verbeken,
W. Weder,
S. Savic,
A. di Lorito,
A. Navarro,
E. Felip,
A. Warth,
P. Baas,
P. Meldgaard,
F. Blackhall,
A. Dingemans,
H. Dienemann,
R. Dziadziuszko,
J. Vansteenkiste,
C. O'Brien,
T. Geiger,
J. Sherlock,
J. Schageman,
U. Dafni,
R. Kammler,
K. Kerr,
E. Thunnissen,
R. Stahel,
S. Peters,
R. Stahel,
R. Rosell,
K. Kerr,
M. Molina,
A. Hiltbrunner,
N. Marti,
Z. Tsourti,
V. Polydoropoulou,
C. O'Brien,
S. Gray,
I. Opitz,
A. Curioni,
D. Lardinois,
E. Speel,
A. Ruland,
G. De Luca,
S. Malatesta,
A. Quinn,
L. Franklin,
W. Biernat,
A. Wrona,
W. Rzyman,
J. Jassem,
L. Madsen,
C. Camps,
E. Jantus-Lewintre,
R. Guijarro,
M. Nicolson,
D. Stevenson,
W. Mathieson,
J. de Jong,
E. Smit,
C. van Setten,
J. D. de Langen,
I. Sansano,
M. Pine,
M. Reid,
Elizabeth Taylor,
K. Nackaerts,
C. Dooms,
E. Wauters,
S. Van Der Borght,
T. Muley
|
6 |
2017 |
6
๐
|
|
๐
|
Effectiveness of PD-(L)1 Inhibitors Alone or in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Non-Squamous Non-Small Cell Lung Cancer (nsq-NSCLC) With PD-L1-High Expression Using Real-World Data.
11 auth.
M. Pรฉrol,
E. Felip,
U. Dafni,
L. Polito,
N. Pal,
Z. Tsourti,
...
Timothy Ton,
D. Merritt,
S. Morris,
R. Stahel,
S. Peters
|
6 |
2022 |
6
๐
|
|
๐
|
Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project.
28 auth.
L. Bubendorf,
U. Dafni,
Martin Schรถbel,
S. Finn,
V. Tischler,
A. Sejda,
A. Marchetti,
E. Thunnissen,
E. Verbeken,
A. Warth,
I. Sansano,
R. Cheney,
E. Speel,
D. Nonaka,
K. Monkhorst,
...
H. Hager,
M. Martorell,
S. Savic,
K. Kerr,
Q. Tan,
Z. Tsourti,
T. Geiger,
R. Kammler,
K. Schulze,
A. Das-Gupta,
D. Shames,
S. Peters,
R. Stahel
|
5 |
2017 |
5
๐
|
